Results 171 to 180 of about 38,480 (291)

Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation : results from the ARISTOTLE Trial [PDF]

, 2012
Gregory C. Flaker, R. Lopes, Sana M. Al‐Khatib, Antonio G. Hermosillo, L. M. Thomas, Jun Zhu, Witold Rużyłło, Puneet Mohan, C. B. Granger, Lars Wallentin   +9 more
openalex  

Effect of Therapeutic Plasma Exchange on Apixaban Plasma Levels. [PDF]

J Pharm Technol
Hensler D, Burghardt D.
europepmc   +1 more source

Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation [PDF]

, 2015
Fabrizio Semeraro, Francesca Incampo, Concetta T. Ammollo, Claudia Dellanoce, Oriana Paoletti, Sophie Testa, Mario Colucci   +6 more
openalex   +1 more source

Dose-reduced apixaban for secondary prophylaxis in patients with severe obesity: a single center analysis. [PDF]

Blood Adv
Rapoport EA, Townsend NW, Farhat N, Patel P, Billett HH.   +4 more
europepmc   +1 more source

Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)

, 2013
Hisao Ogawa, Shinya Goto, Masunori Matsuzaki, Shintaro Hiro, Daisuke Shima, on behalf of the APPRAISE-J investigators   +5 more
openalex   +2 more sources

Prothrombin complex concentrate for the management of severe traumatic bleeding in a patient anticoagulated with apixaban [PDF]

, 2015
R. Durie, Michelle Kohute, Carlos Alexandre Almeida Fernandez, Michael Knight   +3 more
openalex   +1 more source

Recurrent Ischaemic Stroke in a Patient With Left Ventricular Thrombus Despite Apixaban: Successful Transition to Warfarin. [PDF]

Cureus
Patel MI, Kannan S, Jacob RM.
europepmc   +1 more source

A Single Health System Retrospective Qualitative Analysis of Inpatient Apixaban and Rivaroxaban Calibrated Anti-Xa Level Monitoring and Clinical Implications. [PDF]

Hosp Pharm
McCarville B, Osborn J.
europepmc   +1 more source

Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [PDF]

, 2015
Meena P. Rao, Sigrun Halvorsen, Daniel Wojdyla, Laine Thomas, John H. Alexander, Elaine M. Hylek, Michael Hanna, M. Cecilia Bahit, Renato D. Lópes, Raffaele De Caterina, Çetin Erol, Shinya Goto, Fernando Laņas, Basil S. Lewis, Steen Husted, Bernard J. Gersh, Lars Wallentin, Christopher B. Granger   +17 more
openalex   +1 more source

Atrial Fibrillation in Advanced CKD: To Anticoagulate, or Not, and With What? [PDF]

Kidney360
Ajmal MS, Winkelmayer WC.
europepmc   +1 more source